Article

Iridex, Peregrine enter agreement

Iridex Corp. has entered into a global distribution and supply agreement with Peregrine Surgical Ltd. to become a worldwide distributor for Peregrine labeled products, and Peregrine Surgical will become part of the Iridex supply chain.

Mountain View, CA-Iridex Corp. has entered into a global distribution and supply agreement with Peregrine Surgical Ltd. Under the agreement, Iridex will become a worldwide distributor for Peregrine labeled products, and Peregrine Surgical will become part of the Iridex supply chain for the manufacture of certain Iridex products.

“Peregrine is an ideal partner to assist Iridex in not only broadening our channel offering and driving costs out of our supply chain, but we anticipate our partnership will also accelerate product development cycles for new disposable products,” said Will Moore, president and chief executive officer of Iridex.

The arrangement involves Iridex assuming management of Peregrine Surgical’s independent distribution channel in the United States. The integration should provide additional coverage and leverage for both company’s product lines, according to the company.

“Peregrine Surgical has invested in establishing high-quality and efficient manufacturing of surgical instruments,” stated Todd Richmond, president of Peregrine Surgical. “The global reach of Iridex will represent a mutually beneficial partnering for the brand names of both companies.”

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
© 2025 MJH Life Sciences

All rights reserved.